Boston, MA -- (SBWIRE) -- 01/02/2014 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: Matador Resources Co(NYSE:MTDR), Dynavax Technologies Corporation(NASDAQ:DVAX), Dendreon Corporation(NASDAQ:DNDN), Sarepta Therapeutics Inc(NASDAQ:SRPT).
Matador Resources Co(NYSE:MTDR) opened its shares at the price of $19.05 for the day. Its closing price was $18.64 after losing -2.15% for the day. The company traded with the total volume of 1.14 million shares, while its average trading volume remained 885,879 shares. Matador Resources Company is an independent energy company engaged in the exploration, development, production and acquisition of oil and natural gas resources in the United States, with an emphasis on oil and natural gas shale and other unconventional plays.
Has MTDR Found The Bottom and Ready To Move Up? Find Out Here
Dynavax Technologies Corporation(NASDAQ:DVAX) percentage change plunged -2.00% to close at $1.96 with the total traded volume of 5.33 million shares, and average volume of 5.56 million. The 52 week range of the stock remained $0.98 - $3.39, while its day lowest price was $1.91 and it hit its day highest price at $2.02. Dynavax Technologies Corporation (Dynavax) is a clinical-stage biopharmaceutical company, discovers and develops products to prevent and treat infectious and inflammatory diseases.
Has DVAX Found The Bottom And Ready To Gain Momentum? Find Out Here
Dendreon Corporation(NASDAQ:DNDN) started its trading session with the price of $2.99 and closed at $2.99 by losing –1.97%. DNDN stocks traded with total volume of 4.19 million shares, while the average trading volume remained 3.80 million shares. The beta of DNDN stands at 5.04. Day range of the stock was $2.96 -$3.08. Dendreon Corporation (Dendreon) is a biotechnology company focused on the discovery, development and commercialization of therapeutics that may significantly improve cancer treatment options for patients.
Why Should Investors Buy DNDN After the Recent Fall? Just Go Here and Find Out
Sarepta Therapeutics Inc(NASDAQ:SRPT) ended its day with the loss of -1.97% and closed at the price of $20.37 after opening at $20.93. Stock traded during its last trading session with the total volume of 1.55 million shares, as compared to its average volume of 2.17 million shares. Sarepta Therapeutics Inc., formerly AVI BioPharma, Inc., biopharmaceutical company focused on the discovery and development of ribonucleic acid (RNA)-based therapeutics for the treatment of rare and infectious diseases
Will SRPT Get Buyers Even After The Recent Rally? Find Out Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)